In “Validation analyses” appraising previously reported inflammatory marker-cancer risk relationships, we found suggestive evidence for an association of genetically-proxied macrophage migration inhibitory factor concentrations with bladder cancer risk. This evidence concerns the gene MIF and urinary bladder cancer.